Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 56: 1246-1251, 1984;
8750-7587/84 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sprague, R. S.
Right arrow Articles by Lonigro, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sprague, R. S.
Right arrow Articles by Lonigro, A. J.

Journal of Applied Physiology, Vol 56, Issue 5 1246-1251, Copyright © 1984 by American Physiological Society

ARTICLES

Prostaglandin I2 supports blood flow to hypoxic alveoli in anesthetized dogs

R. S. Sprague, A. H. Stephenson and A. J. Lonigro

In an animal model of unilateral alveolar hypoxia, inhibition of cyclooxygenase activity, estimates of immunoreactive 6-ketoprostaglandin F1 alpha (6-keto-PGF1 alpha), and administration of prostaglandin I2 (PGI2) were used to evaluate the hypothesis that endogenous PGI2 opposes hypoxic pulmonary vasoconstriction, thereby producing redistribution of blood flow to hypoxic alveoli and reductions in systemic PO2. In anesthetized dogs, one lung was ventilated with 100% N2 and the other with 100% O2. Thermal dilution coupled with electromagnetic flow measurements permitted estimates of blood flow to each lung. Indomethacin or meclofenamate reduced flow to the N2-ventilated lungs (P less than 0.05) and increased systemic PO2 (P less than 0.05). Simultaneously, aortic concentrations of immunoreactive 6-keto-PGF1 alpha decreased 63 +/- 8% (P less than 0.001). Following cyclooxygenase inhibition, incremental doses of PGI2 (0.01, 0.025, and 0.10 micrograms X kg-1 X min-1) increased flow to the N2-ventilated lungs and reduced systemic PO2 (P less than 0.001) without affecting mixed venous PO2. These results suggest that systemic PO2 was reduced because of increased venous admixture. We conclude that PGI2 attenuates hypoxic vasoconstriction which allows flow to be maintained to hypoxic alveoli, resulting in reduced systemic PO2.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. H. Stephenson, R. S. Sprague, J. L. Losapio, and A. J. Lonigro
Differential effects of 5,6-EET on segmental pulmonary vasoactivity in the rabbit
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2153 - H2161.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. Zhu, E. K. Birks, C. A. Dawson, M. Patel, J. R. Falck, K. Presberg, R. J. Roman, and E. R. Jacobs
Hypoxic pulmonary vasoconstriction is modified by P-450 metabolites
Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1526 - H1533.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
B. E. Marshall, L. Chen, H. F. Frasch, C. W. Hanson, and C. Marshall
Improved oxygenation with prostaglandin F2alpha with and without inhaled nitric oxide in dogs
J Appl Physiol, April 1, 1998; 84(4): 1350 - 1358.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online